Fact CheckerSign in

NCT06655701Recruiting

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis: The Intersection of Muscle Loss and Pelvic Dysfunction

Source: ClinicalTrials.gov · Last updated 12 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The primary aim of our study is to evaluate the presence of stress urinary incontinence in postmenopausal patients with and without osteoporosis, determine its impact on quality of life, and explore its relationship with sarcopenia.

Status (registry)
Recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
22 Oct 2024
Start date
15 Nov 2024
Primary completion date
15 Jan 2025
Lead sponsor
Beylikduzu State Hospital
Diseases
Osteoporosis
NCT number
NCT06655701

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From 15 Nov 2024 to the primary completion date, 15 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of medications that could affect the study results.

Other illness

  • History of neurological diseases, infections, surgeries, or trauma that could cause urinary incontinence or muscle loss.
  • Presence of psychiatric disorders.

Other

  • Refusal to participate in the study.
  • Cognitive impairments.

Who the study is looking for

  • Postmenopausal women with DXA measurements performed within the last 6 months.
  • Based on DXA measurements:
    • Femoral neck and L1-L4 T-scores of -1 and above will be included in the control group (non-osteoporotic).
    • Femoral neck and L1-L4 T-scores of -2.5 and below will be included in the osteoporosis group.
  • Aged 50-75 years

Age in the registry: 50 years to 75 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beylikdüzü State Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.